COST
50
2
CME
48
2
CSCO
64
-12
CAH
66
3
CMG
57
-4
APD
54
-3
AMGN
31
-5
AAP
45
3
VIX
57
13
CF
53
2
BAX
54
4
CB
53
-2
ADT
71
-2
ADSK
59
-3
AA
57
-7
AEP
64
2
BRK.B
33
-3
ALL
41
-3
ADM
47
-4
CMCSA
46
7
COST
50
2
CME
48
2
CSCO
64
-12
CAH
66
3
CMG
57
-4
APD
54
-3
AMGN
31
-5
AAP
45
3
VIX
57
13
CF
53
2
BAX
54
4
CB
53
-2
ADT
71
-2
ADSK
59
-3
AA
57
-7
AEP
64
2
BRK.B
33
-3
ALL
41
-3
ADM
47
-4
CMCSA
46
7
Financhill
Back

Sage Therapeutics Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Buy
62

SAGE
Sage Therapeutics

Last Price:
$9.18
Seasonality Move:
-9.7%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 7.5% based on the past 10 years of stock performance.
  • Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $9.20. The Score for SAGE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • SAGE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 7.5% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Buy
62
Sage Therapeutics (SAGE) is a Buy

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAGE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
13.47
52-Week Low:
4.62

Prediction Charts

Market Cap:
576.1M
Price in USD:
9.20
Volume:
3M
Beta:
1.31

Technical Analysis

SMA50:
7.49
SMA100:
7.50
SMA200:
6.98
52-Wk Change:
-13.37%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 9.20 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-16 9.09 9.07 9.15 8.96
Jun-17 9.06 9.12 9.14 9.03
Jun-18 9.12 9.13 9.33 9.11
Jun-20 9.19 9.30 9.30 9.12
Jun-23 9.26 9.30 9.30 9.18
Jun-24 9.28 9.22 9.30 9.16
Jun-25 9.19 9.25 9.26 9.16
Jun-26 9.21 9.28 9.30 9.18
Jun-27 9.26 9.15 9.28 9.13
Jun-30 9.15 9.12 9.18 9.04
Jul-1 9.07 9.08 9.13 9.05
Jul-2 9.06 9.08 9.17 9.06
Jul-3 9.12 9.20 9.22 9.11
Jul-7 9.15 9.17 9.20 9.11

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.